Загрузка...
30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?
Systemic treatment is the standard treatment for unresectable stage III and IV lung cancer. Nevertheless, a 5–10% death rate has been described within 30 days after the last systemic treatment, suggesting that these patient did not benefit. We analysed the 30-day mortality after start of systemic th...
Сохранить в:
| Опубликовано в: : | ERJ Open Res |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
European Respiratory Society
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6215912/ https://ncbi.nlm.nih.gov/pubmed/30406123 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00030-2018 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|